Wockhardt LimitedNSE: WOCKPHARMA

Press Release Aug 16 2022

· Issued by Wockhardt Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-16-2022-2

Wockhardt Limited has informed the Exchange about press release dated 16-Aug-2022 titled Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222

View Attachment

6ix hasn’t read this filing yet.

Wockhardt Limited on 6ix

Earlier from Wockhardt

Later from Wockhardt

All Wockhardt news releases